Additionally, mechanisms involving other key proteins, such as calcium/calmodulin-dependent protein kinase II inhibitor I (CAMK2N1), which appears to be downregulated via promoter hypermethylation, further emphasize the role of DNMT1 in cancer (Peng W et al., 2023). This evidence concerns the gene DNMT1 and cancer.